| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0004 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.41 | 0.003 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.004 |